Cas9+ conditionally-immortalized macrophages as a tool for bacterial pathogenesis and beyond
- University of California, Berkeley, United States
Abstract
Macrophages play critical roles in immunity, development, tissue repair, and cancer, but studies of their function have been hampered by poorly-differentiated tumor cell lines and genetically-intractable primary cells. Here we report a facile system for genome editing in non-transformed macrophages by differentiating ER-Hoxb8 myeloid progenitors from Cas9-expressing transgenic mice. These conditionally immortalized macrophages (CIMs) retain characteristics of primary macrophages derived from the bone marrow yet allow for easy genetic manipulation and a virtually unlimited supply of cells. We demonstrate the utility of this system for dissection of host genetics during intracellular bacterial infection using two important human pathogens: Listeria monocytogenes and Mycobacterium tuberculosis.
https://doi.org/10.7554/eLife.45957.001Main text
Although CRISPR/Cas9 technology has revolutionized our ability to manipulate genomes, cell-type specific barriers hinder genetic approaches to study many important mammalian cells and tissues. Macrophages are critical innate immune cells involved in tissue development, repair, and homeostasis as well as many microbial infections, but they are difficult to genetically manipulate via transfection or transduction, most likely due to sensitive circuits that sense foreign nucleic acid. Although it is possible to manipulate primary bone marrow derived macrophages (BMMs) using CRISPR/Cas9 technology (Chu et al., 2016), the low transduction and transfection efficiencies observed in these cells results in low editing efficiency or, if transductants can be selected, low cell numbers. These limited cell numbers preclude many biochemical and screening approaches that require many millions of cells. In addition, the short life-span of these cells does not allow for selection of individual mutant clones or subsequent genetic manipulations such as knockout of a second gene or protein overexpression. Because of these limitations many studies rely on either immortalized macrophage-like cell lines, which do not recapitulate important metabolic and inflammatory pathways of primary cells (Andreu et al., 2017), or the time-consuming process of generating transgenic or knockout mice from which to obtain BMMs.
To create an efficient and scalable system for effective genome editing in murine macrophages, we sought to build upon previous studies demonstrating that ectopic expression of an estrogen-regulated version of the homeobox transcription factor Hoxb8 (ER-Hoxb8) can immortalize macrophage progenitors that are self-renewing in the presence of β-estradiol (Knoepfler et al., 2001). Subsequent removal of the hormone activates normal differentiation of these cells into macrophages (Wang et al., 2006) (Figure 1—figure supplement 1a). We envisioned that deriving conditionally immortalized macrophage progenitors from Cas9-expressing mice (Platt et al., 2014) would allow us to perform gene editing in conditionally immortalized cells prior to differentiation, providing the opportunity to cryopreserve either bulk populations or individually-cloned mutant cells. Subsequent differentiation of edited progenitors into macrophages would then generate a theoretically unlimited supply of mutant macrophages for functional studies (Figure 1a). While others have recently taken a similar but limited approach using other lineages of Hoxb8 conditionally immortalized immune cells, we sought to fully establish the efficacy of Cas9+ CIMs for robust gene editing and infection of macrophages (Di Ceglie et al., 2017; Lee et al., 2017; MacDuff et al., 2018).
Figure 1 with 1 supplement see all
Cas9+ CIMs as a tractable system for genome-editing in macrophages.
(a) Graphic overview of gene editing in Cas9+ CIMs. (b) BMMs (left panel), CIMs (middle), or RAW 264.7 cells (right) were visualized with Diff-Quick stain. (c) mRNA levels in BMMs and CIMs was quantified using a Nanostring nCounter. Data are representative of two independent experiments and are presented as log transformed normalized transcript counts of the average of technical duplicates from one experiment. (d) BMMs or CIMs transduced with a scramble guide (CIM scram) were analyzed by flow cytometry for expression of the indicated myeloid cell markers. Data are representative of three independent experiments. (e) IL-6 and IL-12p40 production by BMMs or CIM scram stimulated with the TLR4 ligand LPS or the TLR9 ligand CpG was measured by ELISA. N.D. – none detected. Data are representative of three independent experiments each performed in triplicate, mean ± SD are shown. (f) Genomic DNA from CIMs transduced with 40 guides targeting 17 genes was analyzed for genomic editing by TIDE analysis. (g) CIMs transduced with a scramble guide or guides targeting CD11b or Ifngr1 were stained with the indicated antibodies. Fluorescence minus one (FMO) stained samples were used as controls. (h and I) BMMs or CIMs transduced with a scramble guide or guides targeting Nos2 were stimulated overnight with LPS + IFNγ or left unstimulated and then analyzed by flow cytometry for expression of iNOS (h); nitric oxide production in cell-free supernatants was analyzed by Griess assay (i). Data are representative of two independent experiments each performed in triplicate, mean ± SD are shown. (j) CIM progenitors previously transduced with a lentivirus containing puromycin resistance and a guide targeting Ifngr1 were subsequently transduced with lentivirus containing hygromycin resistance and scramble guide or guides targeting CD11b.
To this end, we harvested hematopoietic stem cells from mice that constitutively express Cas9, infected them with lentivirus expressing the ER-Hoxb8 fusion protein and selected for cells that survived 3–4 weeks of culture in the presence of β-estradiol, as described by Wang, et. al. (Wang et al., 2006). These Cas9+ macrophage progenitors grew robustly in suspension and, upon removal of β-estradiol and addition of MCSF, differentiated into adherent cells that expressed F4/80, a marker of macrophages (Figure 1—figure supplement 1b and c) (Rosas et al., 2011). However, in our initial studies we noted an unusual morphology of this initial population when compared to primary BMMs derived from wild-type C57BL/6 mice (Figure 1—figure supplement 1b); in addition, the cells expressed high levels of CD11c, a cell surface marker more closely associated with dendritic cells (Figure 1—figure supplement 1c). By re-selecting progenitors with high concentrations of the antibiotic G418, the resulting cell population more closely resembled BMMs morphologically (Figure 1—figure supplement 1a and b) and expressed lower levels of CD11c (Figure 1—figure supplement 1c). We speculate that high concentrations of G418 selected for progenitors with greater expression of the Hoxb8 fusion protein, skewing these cells towards a more uniform macrophage-committed progenitor population. Comparison of gross cellular morphology indicates that these Cas9+ CIMs are much more similar to BMMs than transformed macrophage-like lines such as the frequently used RAW 264.7 (Figure 1b). To more globally compare BMMs and CIMs, we used Nanostring technology to measure mRNA levels of over 700 genes associated with myeloid innate immunity and compared the gene expression pattern between the two cell types. While the level of some of these mRNAs were different between BMMs and CIMs, the majority of transcripts were present at remarkably similar levels in both cell populations, consistent with the initial studies of similarly differentiated ER-HoxB8 cells, which demonstrated that these cells express many macrophage-specific genes but did not compare them directly to BMMs (Figure 1c) (Wang et al., 2006).
To determine if Cas9+, gRNA-expressing CIMs possess functional macrophage phenotypes, we infected progenitors with one of three lentiviruses expressing non-targeting scramble gRNAs, selected transductants using puromycin, differentiated the resulting cells, and probed three macrophage characteristics to compare them with BMMs. First, flow cytometric analysis using key myeloid/lymphoid lineage markers revealed that CIMs were indistinguishable from BMMs, with high expression of the myeloid marker CD11b and macrophage marker F4/80, and low expression of CD11c, the monocyte marker Ly6C, and the neutrophil marker Ly6G (Figure 1d). Second, treatment with either lipopolysaccharide (LPS) (which engages TLR4) or CpG DNA (TLR9 agonist) induced the pro-inflammatory cytokines IL-6 and IL-12p40 from both CIMs and BMMs (Figure 1e). Although the levels were slightly different between the two cell types at these time points, it is clear that CIMs responded vigorously to innate immune stimulation upon engagement of pattern recognition receptors. Finally, CIMs and BMMs upregulated iNOS and generated similar levels of nitric oxide in response to stimulation with LPS plus interferon-γ (IFNγ) (Figure 1h and i). Based on these results, we conclude that transduced Cas9+ CIMs share many of the characteristics of BMMs.
To broadly assess genome editing efficacy in Cas9+ CIMs, we introduced 40 individual gRNAs targeting a total of 17 genes into these cells, selected for puromycin resistant cells, and assessed genome editing in the resulting populations by PCR amplification of the target sites and sequence analysis using Tracking Indels by Decomposition (TIDE) analysis (Brinkman et al., 2014). We found that over 80% of these gRNA transductions resulted in at least 70% editing of the target gene after differentiation, with the majority achieving 80–100% editing efficiency (Figure 1f). For all 11 genes independently targeted with three distinct gRNAs, we obtained >80% editing from at least one guide RNA. To test whether genome editing in these polyclonal populations resulted in significant differences in protein levels, we examined surface expression of CD11b and IFNγ receptor after transduction with gRNAs targeting CD11b or Ifngr1 and found that over 90% of CIMs had substantially reduced expression of the targeted protein as assessed by flow cytometry (Figure 1g). Likewise, transduction with lentiviruses encoding one of three separate guides targeting Nos2, the gene encoding the inducible nitric oxide synthase (iNOS), effectively blocked iNOS expression (Figure 1h) and production of NO (Figure 1i) in response to LPS + IFNγ in all three CIM populations. Although gene-to-gene variability in CRISPR/Cas9-mediated targeting efficiency will certainly exist, taken together our data indicate that independent transduction with three distinct gRNAs per gene in Cas9+ CIMs will disrupt the majority of genes efficiently enough to produce phenotypically relevant changes in gene expression using bulk populations of transduced cells.
Another major advantage of the Cas9+ CIM system is its potential for studying genetic interactions by generating double gene knockouts in the immortalized progenitor state prior to differentiation. To this end, we transduced Cas9+ macrophage progenitors with a lentivirus containing puromycin resistance and targeting Ifngr1 and subsequently transduced the resulting population with lentiviruses containing hygromycin resistance and expressing one of three CD11b or scramble guides. After differentiation of these doubly-resistant populations, over 90% of CIMs lacked both IFNγR1 and CD11b protein expression as assessed by flow cytometry (Figure 1j). This iterative approach provides a robust way to generate double knockouts, enabling a simple methodology to elucidate synthetic interactions. Overall, our results establish Cas9+ CIMs as an efficient and robust model for genome editing in macrophages with distinct advantages to standard transformed macrophage-like cell lines.
To more specifically test whether CIMs are effective for studying the antimicrobial functions of macrophages, we assessed the host and microbe requirements of two well-established bacterial pathogens that naturally infect macrophages, Listeria monocytogenes and Mycobacterium tuberculosis. First, L. monocytogenes incubated with either BMMs or CIMs were effectively phagocytosed, replicated robustly, and spread to neighboring macrophages (Figure 2a and c). After phagocytosis, L. monocytogenes ruptures phagosomal membranes using its secreted pore-forming toxin listeriolysin O (LLO, encoded by the hly gene) in order to grow in the cytosol, and expresses ActA to hijack the host actin polymerization machinery in order to propel itself through the cytosol and mediate spread to neighboring cells (Portnoy et al., 2002). Importantly, L. monocytogenes lacking LLO (Δhly) were unable to grow in BMMs or CIMs, and bacteria lacking ActA (ΔactA) failed to recruit actin and spread (Figure 2b). Thus, the major bacterial virulence determinants required for L. monocytogenes infection are the same for BMMs and CIMs.
Figure 2
Cas9+ CIMs as an in vitro model for Listeria monocytogenes infection.
(a) BMMs (left panel) or CIMs (right) were infected with WT Listeria monocytogenes at MOI = 0.25 and monolayers were visualized with Diff-Quick stain at 8 hr post-infection. Data are representative of two independent experiments. (b) BMMs (top three panels) or CIMs (lower panels) were infected for 5 hr with three strains of L. monocytogenes: WT, Δhly, and ΔactA at MOI = 1.5. Nuclei shown in blue, bacterial cells in red, and F-actin in green. (c) BMMs (left panel) or CIMs transduced with a scramble gRNA were infected with three strains of L. monocytogenes: WT, an autophagy-sensitive strain that lacks ActA, PlcA and PlcB (Mitchell et al., 2018) and Δhly at MOI = 0.25. Bacterial densities were enumerated by CFU at t = 0.5 h and indicated hours post-infection. Data are representative of two independent experiments each performed in triplicate, mean ± SD are shown. (d) CIMs transduced with the indicated gRNAs were infected with WT L. monocytogenes or the autophagy-sensitive L. monocytogenes mutant at MOI = 0.75 and bacterial density was enumerated by CFU at t = 8 hr. Data are representative of two independent experiments each performed in triplicate, mean ± SD are shown.
Targeting microbes for destruction via the host autophagy pathway, a process termed xenophagy, is a major mechanism employed by primary macrophages for controlling intracellular pathogens, including L. monocytogenes (Gomes and Dikic, 2014). To determine whether CIMs are capable of restricting L. monocytogenes through autophagy targeting, we used a previously characterized bacterial mutant strain lacking three key virulence factors (ActA, PlcA, PlcB) required for microbial evasion of autophagy in BMMs (Mitchell et al., 2018). Kinetic growth assays revealed that this autophagy-sensitive L. monocytogenes strain, and the LLO-defective L. monocytogenes mutant, are both significantly attenuated in both BMMs and CIMs (Figure 2c). Bacterial burden associated with all three strains of L. monocytogenes was somewhat reduced in CIMs compared to BMMs, which we speculate is due to enhanced early killing by the phagolysosomal pathway. Similar results have been observed in peritoneal macrophages, which more effectively engage LC3-associated phagocytosis and are more microbicidal than BMMs against L. monocytogenes early in infection (Gluschko et al., 2018; Herskovits et al., 2007). To examine host genetics of microbial autophagy targeting, we generated CIMs deficient in one of several key components of the autophagy pathway and subsequently infected them with WT L. monocytogenes and the autophagy-sensitive strain. Abrogation of the autophagy pathway through knockout of Atg5, Atg7, or Atg16l1 restored replication of the autophagy-sensitive L. monocytogenes strain relative to scramble CIM controls (Figure 2d), demonstrating that xenophagic targeting is intact and functional in CIMs.
Mycobacterium tuberculosis is a major human pathogen and its ability to replicate and persist within macrophages, as well as to interact with the adaptive immune system, is central to its long-term pathogenic strategy (Upadhyay et al., 2018). Its most important virulence determinant is the type VII protein secretion system termed ESX-1, which is critical for growth in macrophages and influences the innate immune responses of these cells (Stanley et al., 2003). To assess CIMs as a model for studying M. tuberculosis invasion of macrophages, we infected BMMs and CIMs with auto-luminescent M. tuberculosis strains and quantified bacterial replication over a five-day time course. We found that wild-type M. tuberculosis grew robustly in CIMs, with kinetics comparable to that observed in BMMs (Figure 3a). CIM monolayers began to lose integrity six days after infection as the macrophages initiated cell death, a hallmark of M. tuberculosis infection (Chen et al., 2008), which occurred slightly earlier than in BMM monolayers (data not shown). To determine whether ESX-1 is required for M. tuberculosis replication in CIMs, we also infected both macrophage types with an auto-luminescent M. tuberculosis strain lacking the core ATPase for the secretion system, eccC, which results in complete loss of ESX-1 secretion (Rosenberg et al., 2015). As expected, these mutant bacteria were unable to replicate in BMMs or CIMs, indicating that the requirements for M. tuberculosis replication are the same for both types of macrophages (Figure 3a).
Figure 3 with 1 supplement see all
Cas9+ CIMs as an in vitro model for Mycobacterium tuberculosis infection.
(a) Luminescent bacterial growth assay. BMMs (black) vs. CIMs transduced with a scramble guide (green) were infected with M. tuberculosis-Erdman (solid bars) or a ΔeccC M. tuberculosis-Erdman strain (patterned bars) carrying the luxCDABE reporter operon at MOI = 0.5. Data are representative of two independent experiments each performed in triplicate, mean ± SD are shown. (b) Luminescent bacterial growth assay as in a, BMMs (black), CIMs transduced with a scramble guide (green), or CIMs transduced with a guide targeting Ifngr (purple) were infected with M. tuberculosis-Erdman Lux. Patterned bars indicate conditions where the different cell types were treated with IFNγ prior to and throughout infection. Fold-change in luminescence is reported as M. tuberculosis growth relative to t = 0 for each condition. Data are representative of four independent experiments each performed in triplicate, mean ± SD are shown. (c–f) mRNA levels in BMMs and CIMs, either uninfected or infected with WT (c) or ΔeccC M. tuberculosis (d) at MOI = 5 at 6 hr post infection were quantified using a Nanostring nCounter. Data are representative of two independent experiments. Source data is available as Figure 3—source data 1. c and (d) Data are presented as fold changes of infected/uninfected values of the average of technical duplicates from one experiment. (e) Log-transformed, normalized transcript counts for the indicated genes obtained from BMMs (black) vs. CIMs (green) before (patterned bars) or after infection with WT M. tuberculosis (solid bars). (f) Transcript counts for the indicated genes obtained from BMMs (black) vs. CIMs (green) infected with WT M. tuberculosis (solid bars) or M. tuberculosis ΔeccC (patterned bars). Transcripts were normalized to counts in WT M. tuberculosis infected macrophages.
-
Figure 3—source data 1
mRNA levels in BMMs and CIMs, uninfected or infected with M.
tuberculosis.
- https://doi.org/10.7554/eLife.45957.007
IFNγ-mediated activation of macrophage antimicrobial defenses during in vivo infection is critical for host resistance to M. tuberculosis infection, and ex vivo treatment of cultured macrophages with this cytokine induces BMMs to inhibit bacterial replication (Flynn et al., 1993). Importantly, addition of IFNγ to CIMs transduced with lentivirus encoding scramble gRNA restricted M. tuberculosis growth to a similar extent as IFNγ treated BMMs (Figure 3b). Abrogating IFNγ signaling through knockout of Ifngr1 (Figure 1g) restored replication of M. tuberculosis in IFNγ treated CIMs (Figure 3b). These data indicate that CIMs can provide the environmental conditions required for M. tuberculosis growth, but also have the inducible capacity to restrict bacterial replication.
Macrophage-like cell lines and BMMs have been demonstrated to induce markedly different responses after M. tuberculosis infection (Andreu et al., 2017). To determine how closely CIMs resemble BMMs during infection with M. tuberculosis, we globally compared gene expression of BMMs and CIMs during infection with either a virulent WT M. tuberculosis Erdman strain or M. tuberculosis ΔeccC lacking a functional ESX-1 secretion system using the same 700 myeloid gene panel as described above. There was strong correlation between the genes induced by BMMs and CIMs in response to both WT and ΔeccC M. tuberculosis (Figure 3c and d). Lentiviral transduction with a non-targeting gRNA did not significantly alter the response of CIMs to M. tuberculosis (Figure 3—figure supplement 1a). In contrast to the comparison between BMMs and CIMs, there was weak correlation between the genes induced by RAW 264.7 cells and BMMs or CIMs in response to M. tuberculosis (Figure 3—figure supplement 1b and c). Both BMMs and CIMs activated genes known to be involved in M. tuberculosis infection, including Cd40, Il1b, Nos2, Ptgs2, Tlr2, and Tnf (Andreu et al., 2017) (Figure 3e). As previously demonstrated in BMMs, we observed that many interferon-stimulated genes were more highly induced upon infection with WT M. tuberculosis than M. tuberculosis lacking ESX-1 in both BMMs and CIMs (Manzanillo et al., 2012; Stanley et al., 2007) (Figure 3f). Overall, these results establish CIMs as a suitable model for M. tuberculosis infection of macrophages.
Our results establish Cas9+ CIMs as a powerful ex vivo model of macrophage biology and represent a major technological advance in our ability to capitalize on powerful genome editing capabilities in this notoriously refractory cell type. We expect that the methods we have developed will lay the foundation for investigations exploring new pathways that mediate the many roles of this important cell type in mammalian biology (Wynn et al., 2013). Indeed, while we show that Cas9+ CIMs are a flexible tool for studying some important aspects of innate immunity and inflammation, they are also likely to be useful for unbiased screening of CRISPR libraries to identify pathways important for other macrophage functions including tissue homeostasis and metabolic reprogramming. Because Cas9+ CIMs can give rise to an unlimited number of mutant macrophages, this scalable system can generate genetically defined mutant macrophages for use in a wide range of applications, from in vitro biochemical approaches to in vivo adoptive transfer studies of mice (Redecke et al., 2013; Wiesmeier et al., 2016). Furthermore, using an iterative genome-editing approach, Cas9+ CIMs allow for facile exploration of large-scale genetic interactions. Thus, this system represents a significant technological advance that will likely promote the study of macrophages and their myriad functions.
Materials and methods
Key resources table
| Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
|---|---|---|---|---|
| Strain, strain background (M. musculus) | WT C57BL/6J | Jackson Laboratory | Stock No: 000664 | |
| Genetic reagent (M. musculus) | Rosa26-Cas9 knockin mouse | Jackson Laboratory | Stock No: 026179 | Platt et al., 2014 |
| Recombinant DNA reagent | ER-Hoxb8-MSCV-Neo | Wang et al., 2006 | ||
| Recombinant DNA reagent | pLentiGuide-Puro | Addgene | 52963 | |
| Recombinant DNA reagent | lenti-sgRNA hygro | Addgene | 104991 | |
| Strain, strain background (M. tuberculosis) | Erdman strain | BEI Cat # NR-15404 | ||
| Genetic reagent (M. tuberculosis) | ΔeccC (Erdman, ΔeccCa1-ΔeccCb1) | Rosenberg et al., 2015 | ||
| Genetic reagent (M. tuberculosis) | Lux (Erdman expressing the luxCDABEoperon) | Braverman et al., 2016 | ||
| Genetic reagent (M. tuberculosis) | ΔeccC Lux | Penn et al., 2018 | ||
| Strain, strain background (L. monocytogenes) | 10403S strain | PMID: 24667708 | ||
| Genetic reagent (L. monocytogenes) | ΔactA | PMID: 10931865 | DP-L3078 | |
| Genetic reagent (L. monocytogenes) | Δhly | PMID: 7960143 | DP-L2161 | |
| Genetic reagent (L. monocytogenes) | ΔactA PlcAH86APlcBH69G | Mitchell et al., 2018 | DP-L6586 | |
| Commercial assay or kit | nCounter Mouse Myeloid Innate Immunity Panel | NanoString |
Cell culture
View detailed protocolBone marrow derived macrophages (BMMs) were generated from the femurs and tibias from wild-type C57BL/6 (The Jackson Laboratory) mice that were 8–12 weeks old. Conditionally-immortalized macrophages (CIMs) were derived from bone marrow cells from a 5-FU treated male Cas9+ mouse (Platt et al., 2014). Hoxb8 immortalized cells were generated as previously described (Wang et al., 2006) with the modification that progenitors in bone marrow were enriched by negative depletion; cells expressing CD11b, Ter119, B220, CD5, CD19, and Gr-1 were depleted using biotinylated antibodies and streptavidin coated dynabeads. For re-selection of CIM progenitors, cells were cultured in 10 mg/ml G418 for 7 days. All mice were housed in specific-pathogen free conditions and treated using procedures described in animal care protocols approved by the Institutional Animal Care and Use Committee of UC Berkeley.
Progenitor CIMs prior to differentiation were maintained in RPMI (Gibco) supplemented with 10% FBS, 2% GM-CSF supernatant produced by a B16 murine melanoma cell line, 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEPES, 43 uM β-mercaptoethanol, and 2 uM β-estradiol (Sigma #E2758). Progenitor CIMs were maintained in suspension in non-treated tissue culture treated flasks at densities below 500,000 cells/ml before removal of β-estradiol and differentiation. BMMs and differentiated CIM macrophages were cultured in macrophage media: DMEM (Gibco) supplemented with 10% FBS, 10% M-CSF supernatant produced by 3T3-MCSF cells as previously described, 2 mM L-glutamine (Gibco), and 1 mM sodium pyruvate (Gibco). RAW 264.7 cells were cultured in DMEM (Gibco) supplemented with 10% FBS, 2 mM L-glutamine (Gibco), and 20 mM HEPES. To differentiate progenitor CIMs into macrophages, cells were washed twice in PBS + 1% FBS to fully remove β-estradiol, resuspended in complete macrophage media, and seeded onto non-treated 15 cm tissue culture plates at 5.0 × 106 cells/plate in 20 ml of media. Differentiating CIM macrophages were given an additional 10 ml of macrophage media on days 3 and 6 post-differentiation, and terminal assays were performed at day 9 or 10 post-differentiation.
Transfection, transduction, genotyping, and sequence analysis
Request a detailed protocolCRISPR guide sequences targeting genes of interest were selected from the murine Brie guide library. Oligonucleotides encoding the chosen gRNAs (see Supplementary file 1) were cloned into pLentiGuide-Puro (Addgene #52963) or lenti-gRNA hygro (Addgene #104991), and verified by sequencing using the human U6 sequencing primer. 293 T cells were co-transfected with pLentiGuide-Puro, psPAX2, and pMD2.G using Lipofectamine and Optimem according to manufacturer's guidelines to generate lentiviral particles for trandsuction into Cas9-expressing CIM progenitors. For optimal transduction of Cas9-expressing CIM progenitors, 5.0 × 105 cells/well in a 6-well plate were spinfected at 1000xg for 2 hr at 32°C in the presence of 10 µg/ml protamine sulfate. Two days post-transduction, 12 µg/ml puromycin was added to cells, and cells were selected in puromycin for 4 days. Puromycin-resistant cells were maintained as polyclonal populations and total gDNA was extracted using DNeasy Blood and Tissue kit (Qiagen). To generate double knockout progenitors, puromycin-resistant progenitors that had previously been transduced with pLentiGuide-Puro were transduced with lenti-sgRNA hygro and selected using 250 µg/ml hygromycin for 8 days. The genomic sites encompassing targeted guide regions were amplified by PCR using iProof polymerase (BioRad) and sequenced, and population level genome editing was estimated using the TIDE webtool (https://tide.deskgen.com/) as originally described (Brinkman et al., 2014). Guide genome editing efficiencies displayed were a combination of data from CIMs before and after G418 selection, with no notable difference in editing efficiency caused by G418 selection.
Mycobacterium tuberculosis infection
Request a detailed protocolCIMs or BMMs were seeded at 60,000 cells per well onto white, clear-bottom CellBind 96-well plates (Corning) or 12-well TC-treated plates (Corning) in macrophage media one or two days prior to infection. For pre-treatment of macrophages with IFN-γ, post-seeding cell culture media was switched to media with 1.5 ng/µl of recombinant murine IFN-γ (Peprotech) 12–18 hr prior to infection, and activated cells were subsequently cultured in IFN-γ containing media throughout infection.
Macrophages were infected with M. tuberculosis as previously described (Penn et al., 2018). The M. tuberculosis strain Erdman the ΔeccC strain made in the Erdman background, or the WT or ΔeccC strain made in the Erdman background expressing the luxCDABE operon (Braverman et al., 2016; Penn et al., 2018; Rosenberg et al., 2015) were used for all infections. All Mtb strains were cultured in 7H9 liquid media (BD) supplemented with 10% Middlebrook OADC (Sigma), 0.5% glycerol, 0.05% Tween-80 in roller bottles at 37°C. Briefly, mid-log M. tuberculosis cultures were washed twice with PBS, gently sonicated to disperse clumps, and resuspended in phagocytosis infection media (DMEM supplemented with 5% horse serum and 5% FBS). For luminescence assays macrophages were infected in at least triplicate wells by removing media from cells, and monolayers were overlaid with the bacterial suspensions in phagocytosis media then incubated at 37°C for 4 hr, after which infection media was removed and fresh macrophage media was added. Bacterial luminescence signal was measured at 32°C at the time of infection and every day starting 48 hr post-infection after daily media changes. All growth measurements are normalized to day 0 luminescence readings for each infected well and are presented as fold change in luminescence compared to day 0. Cells were infected at a multiplicity of infection (MOI) of 5 for RNA analysis and 0.5 for assays monitoring bacterial growth.
Listeria monocytogenes infection
Request a detailed protocolThe WT 10403S, ΔactA (DP-L3078), Δhly (DP-L2161) and the autophagy-sensitive ΔactA PlcAH86A PlcBH69G (DP-L6586) strains (Mitchell et al., 2018) (Cheng et al., 2018) were grown overnight in brain heart infusion (BHI) medium at 30°C before each experiment. Infections of macrophages were performed as previously described (Cheng et al., 2018; Mitchell et al., 2018) with few modifications. BMMs and CIMs were seeded on round 12 mm coverslips (Fisher Scientific, Hampton, NH, USA) and incubated overnight at 37°C and 5% CO2. Coverslips were incubated with a solution 0.1% gelatin for 1 hr at 37°C and washed twice with PBS prior seeding CIMs. Macrophages were infected at various MOIs, washed at 0.5 hr post-infection and further incubated in fresh medium. At 1 hr post-infection, 50 µg/ml of gentamicin was added to the medium in order to kill extracellular bacteria. MOIs and incubation times are indicated in figure legends.
Flow cytometry
Request a detailed protocolCells were fixed with Fix/Perm buffer (BD) for 20 min at 4°C. All stains were carried out in PBS containing 2% FBS (v/v) including anti-CD16/32 Fc blocking antibody (clone 93, BioLegend). Cells were stained for 20 min at 4°C with antibodies against F4/80 (clone BM8, Tonbo Biosciences), CD11b (clone M1/70, Tonbo Biosciences), CD11c (clone N418, Tonbo Biosciences), Ly6C (clone HK 1.4, BioLegend), Ly6G (clone 1A8, Tonbo Biosciences), IFNγR1 (clone 200, eBioscience) or iNos (clone CXNFT, eBioscience). All cells were analyzed on an LSR Fortessa (BD Biosciences), and data was analyzed with FlowJo.
TLR ligand and IFNγ stimulations
Request a detailed protocolCells were seeded at 60,000 cells per well in 96-well CellBind plates (Corning) in macrophage media the day prior to stimulation. For cytokine analysis cells were stimulated with 1 µg/ml LPS (InvivoGen) or 1 uM CpG-1668 (InvivoGen, Tlrl-1668) for 16–20 hr. Cell-free supernatants were harvested and frozen at −20°C prior to analysis. For Griess assay analysis, cells were stimulated with 100 ng/ml LPS and 5 ng/ml IFNγ. After 24 hr cell-free supernatant was harvested and immediately analyzed.
ELISA
Request a detailed protocolCell-free supernatants from stimulated cells were analyzed by ELISA to enumerate cytokine production. Supernatants were absorbed onto a 96-well Nunc MaxiSorp flat-bottom plate (44-2404-21, Invitrogen) coated with the following capture antibodies diluted in 0.1M sodium phosphate buffer pH 8.0 and incubated overnight at 4°C: IL-6 (clone MP5-20F3, 554400, BD Biosciences, 1 μg/ml) and IL-12 p40 (clone C15.6, 14-7125-81, eBioscience, 1 μg/ml). The following day, plates were washed 3x with PBS + 0.05% Tween-20 and blocked with PBS + 1% BSA for 4 hr at RT. Recombinant cytokines for standard measurements were serially diluted in PBS/BSA. IL-6 (406 ML-025, R and D) IL-12 p40 (34-8321-63, eBioscience) and experimental supernatants were incubated overnight at 4°C. After 3X washes in PBS/BSA, biotin-conjugated sandwich antibodies were incubated on supernatants and standards (IL-6, MP5-32C11, 554402, BD Biosciences and p40 C17.8, 13-7123-85, eBiosciences) and detected by Streptavidin-HRP (BD Biosciences, 1:3000). For the development step, ELISA was incubated with OPD (Sigma) and 30% hydrogen peroxide, followed by incubation with 3M HCl. Absorbance at 490 nm was read on an Infinite M200 Tecan plate reader.
Griess assay
Request a detailed protocolCell-free supernatants from stimulated cells were analyzed by Griess reaction to detect nitrite as a proxy for NO production. A solution of 0.2% napthylethylenediamine dihydrochloride was mixed 1:1 with a 2% sulfanilamide/4% phosphoric acid solution. 100 µl of this solution was mixed with 100 µl of sample supernatant and absorbance at 546 nm was immediately measured. Nitrite concentrations were determined using a standard curve of sodium nitrite.
Immunofluorescence microscopy and Diff-Quick staining
Request a detailed protocolCoverslips seeded with macrophages were left uninfected or infected with L. monocytogenes, stained with a Diff-Quick stain set (Dade Behring, Deerfield, IL, USA), air-dried and mounted on glass slides using a drop of Permount (Fisher Scientific). Immunofluorescence staining of macrophages infected with L. monocytogenes was performed using a polyclonal rabbit antisera that recognizes L. monocytogenes (BD Biosciences, San Jose, CA, USA), a rhodamine red‐X goat anti‐rabbit IgG (Invitrogen, Carlsbad, CA, USA), phalloidin AlexaFluor‐647 (Invitrogen) and ProLong Gold antifade reagent containing 4′6,‐diamidino‐2‐phenylindole (Invitrogen), as previously described (Cheng et al., 2018). All images were acquired with a KEYENCE BZ‐X710 fluorescent microscope using a 100 × objective and post-treated using the haze reduction function of the BZ‐X analyser software. Images showed in Figure 2B were obtained by staking 10 layers covering 5 μm of thickness and pseudo-colored.
mRNA analysis using nanostring Ncounter
Request a detailed protocolTotal RNA was isolated using TRIzol (Fisher) and the PureLink RNA Mini Kit (12183018A, Ambion), NEB DNase treated, and purified using RNA clean and concentrator columns (Zymo). RNA was analyzed using the mouse myeloid innate immunity panel of the NanoString nCounter Analysis System (NanoString Technologies). Raw counts of samples were normalized according to the manufacturer’s recommendations using reference genes as internal controls (Sdha, Oaz1, Rpl19, Edc3, Sap130, Hdac3, Polr2a, Ppia, Gusb, Tbp, Sf3a3, and Abcf1). Background threshold was set to the geometric mean of the negative controls. Normalization was performed using nSolver Analysis Software v4. Normalized transcript counts are shown in Figure 3—source data 1.
Statistics
Statistical analysis of data was performed using GraphPad Prism software (Graphpad, San Diego, CA). Results are reported as the mean ± SD. Pearson correlation coefficients and R2 values for scatter plots of mRNA expression were determined using log transformed data.
Data availability
All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 3.
References
-
HIF-1α is an essential mediator of IFN-γ-dependent immunity to Mycobacterium tuberculosisThe Journal of Immunology 197:1287–1297.https://doi.org/10.4049/jimmunol.1600266
-
Easy quantitative assessment of genome editing by sequence trace decompositionNucleic Acids Research 42:e168.https://doi.org/10.1093/nar/gku936
-
Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage deathThe Journal of Experimental Medicine 205:2791–2801.https://doi.org/10.1084/jem.20080767
-
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infectionJournal of Experimental Medicine 178:2249–2254.https://doi.org/10.1084/jem.178.6.2249
-
Autophagy in antimicrobial immunityMolecular Cell 54:224–233.https://doi.org/10.1016/j.molcel.2014.03.009
-
The metabolic regulator mTORC1 controls terminal myeloid differentiationScience Immunology 2:eaam6641.https://doi.org/10.1126/sciimmunol.aam6641
-
Hoxb8 conditionally immortalised macrophage lines model inflammatory monocytic cells with important similarity to dendritic cellsEuropean Journal of Immunology 41:356–365.https://doi.org/10.1002/eji.201040962
-
Tuberculosis and the art of macrophage manipulationPathogens and Disease 76:.https://doi.org/10.1093/femspd/fty037
Article and author information
Author details
Funding
National Institutes of Health (P01AI063302)
- Gregory M Barton
- Jeffery S Cox
National Institutes of Health (U19AI135990)
- Gregory M Barton
- Jeffery S Cox
National Institutes of Health (DP1AI24619)
- Jeffery S Cox
National Institutes of Health (R01AI072429)
- Gregory M Barton
Life Sciences Research Foundation (Open Philanthropy Fellow)
- Allison W Roberts
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
We thank Nevan J Krogan as well as members of the Cox, Barton, and Stanley labs for helpful discussions and advice. This work was supported by NIH Grants P01 AI063302 (JSC and GMB), U19 AI135990 (JSC and GMB), DP1 AI124619 (JSC), R01 AI072429 (GMB). Allison Roberts is an Open Philanthropy Fellow of the Life Sciences Research Foundation.
Ethics
Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All mice were treated using procedures described in animal care protocols approved by the Institutional Animal Care and Use Committee of UC Berkeley (Protocol # AUP-2015-11-8096-1).
Copyright
© 2019, Roberts et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 9,596
- views
-
- 912
- downloads
-
- 30
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Cas9+ conditionally-immortalized macrophages as a tool for bacterial pathogenesis and beyond
eLife 8:e45957.
https://doi.org/10.7554/eLife.45957
Further reading
-
- Immunology and Inflammation
Chronic antigenic stimulation can trigger the formation of interleukin 10 (IL-10)-producing T-regulatory type 1 (TR1) cells in vivo. We have recently shown that murine T-follicular helper (TFH) cells are precursors of TR1 cells and that the TFH-to-TR1 cell transdifferentiation process is characterized by the progressive loss and acquisition of opposing transcription factor gene expression programs that evolve through at least one transitional cell stage. Here, we use a broad range of bulk and single-cell transcriptional and epigenetic tools to investigate the epigenetic underpinnings of this process. At the single-cell level, the TFH-to-TR1 cell transition is accompanied by both, downregulation of TFH cell-specific gene expression due to loss of chromatin accessibility, and upregulation of TR1 cell-specific genes linked to chromatin regions that remain accessible throughout the transdifferentiation process, with minimal generation of new open chromatin regions. By interrogating the epigenetic status of accessible TR1 genes on purified TFH and conventional T-cells, we find that most of these genes, including Il10, are already poised for expression at the TFH cell stage. Whereas these genes are closed and hypermethylated in Tconv cells, they are accessible, hypomethylated, and enriched for H3K27ac-marked and hypomethylated active enhancers in TFH cells. These enhancers are enriched for binding sites for the TFH and TR1-associated transcription factors TOX-2, IRF4, and c-MAF. Together, these data suggest that the TR1 gene expression program is genetically imprinted at the TFH cell stage.
-
- Genetics and Genomics
- Immunology and Inflammation
Systemic lupus erythematosus (SLE) is an autoimmune disease, the pathophysiology and genetic basis of which are incompletely understood. Using a forward genetic screen in multiplex families with SLE, we identified an association between SLE and compound heterozygous deleterious variants in the non-receptor tyrosine kinases (NRTKs) ACK1 and BRK. Experimental blockade of ACK1 or BRK increased circulating autoantibodies in vivo in mice and exacerbated glomerular IgG deposits in an SLE mouse model. Mechanistically, NRTKs regulate activation, migration, and proliferation of immune cells. We found that the patients’ ACK1 and BRK variants impair efferocytosis, the MERTK-mediated anti-inflammatory response to apoptotic cells, in human induced pluripotent stem cell (hiPSC)-derived macrophages, which may contribute to SLE pathogenesis. Overall, our data suggest that ACK1 and BRK deficiencies are associated with human SLE and impair efferocytosis in macrophages.
